Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Cash Flow (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Net Cash Flow readings, the most recent being $372.8 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 421.93% to $372.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $480.0 million, a 2751.93% increase, with the full-year FY2025 number at $480.0 million, up 2751.93% from a year prior.
  • Net Cash Flow hit $372.8 million in Q4 2025 for Neurocrine Biosciences, up from $76.4 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $372.8 million in Q4 2025 to a low of -$256.6 million in Q2 2024.
  • Median Net Cash Flow over the past 5 years was $39.3 million (2021), compared with a mean of $26.6 million.
  • Biggest five-year swings in Net Cash Flow: plummeted 794.16% in 2022 and later surged 421.93% in 2025.
  • Neurocrine Biosciences' Net Cash Flow stood at $29.7 million in 2021, then surged by 75.08% to $52.0 million in 2022, then tumbled by 182.5% to -$42.9 million in 2023, then crashed by 169.93% to -$115.8 million in 2024, then surged by 421.93% to $372.8 million in 2025.
  • The last three reported values for Net Cash Flow were $372.8 million (Q4 2025), $76.4 million (Q3 2025), and $69.7 million (Q2 2025) per Business Quant data.